Tislelizumab in combination with gemcitabine plus cisplatin chemotherapy as first-line adjuvant treatment for locally advanced or metastatic bladder cancer: a retrospective study

Xiang Ren(University of Electronic Science and Technology of China), Yiqun Tian(Tongji Hospital), Zhixian Wang(Harbin Institute of Technology), Ruibao Chen(Tongji Hospital), Ying Zhan(Hebei Medical University), Xing Li(Tongji Hospital), Yisheng Yin(Nanjing University), Jing Wang(Inserm)
BMC Urology
August 20, 2022
Cited by 23


Related Papers